Differential effects of IGF-I and insulin on glucoregulation and fat metabolism in depancreatized dogs. 1990

A Giacca, and R Gupta, and S Efendic, and K Hall, and A Skottner, and L Lickley, and M Vranic
Department of Physiology, University of Toronto, Canada.

The effects of equipotent glucose-lowering doses of insulinlike growth factor I (IGF-I) and insulin on tracer-determined glucose kinetics and several metabolites were compared in 14 experiments (7 in each group) in fasted, totally depancreatized dogs. This model prevented variations in insulin secretion induced by IGF-I and permitted evaluation of the effects of IGF-I on extrapancreatic glucagon. Steady-state moderate hyperglycemia (9.9 +/- 0.2 mM) was maintained by a subbasal intraportal infusion of insulin (1.29 +/- 0.17 pmol.kg-1.min-1). This was continued throughout the experiment, allowing evaluation of IGF-I effects on insulin clearance. Human recombinant IGF-I or insulin was given intravenously as a primed infusion for 90 min, followed by a 50-min recovery period. The dose of IGF-I was a 2.6-nmol/kg bolus plus 57.4 pmol.kg-1.min-1. The insulin dose required to induce the same plasma glucose decline as IGF-I (44 +/- 6 vs. 43 +/- 5%, NS) was 9-12 times lower (0.06-nmol/kg bolus + 6.4 +/- 0.6 pmol.kg-1.min-1). However, the mechanism of this decline differed with IGF-I and insulin; glucose production was much less suppressed (25 +/- 9 vs. 42 +/- 11%, P less than 0.001) and glucose utilization was more stimulated (68 +/- 18 vs. 38 +/- 19%, P less than 0.05) with IGF-I.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D008297 Male Males
D010180 Pancreatectomy Surgical removal of the pancreas. (Dorland, 28th ed) Pancreatectomies
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013002 Somatomedins Insulin-like polypeptides made by the liver and some fibroblasts and released into the blood when stimulated by SOMATOTROPIN. They cause sulfate incorporation into collagen, RNA, and DNA synthesis, which are prerequisites to cell division and growth of the organism. Sulfation Factor,Somatomedin,Factor, Sulfation
D050356 Lipid Metabolism Physiological processes in biosynthesis (anabolism) and degradation (catabolism) of LIPIDS. Metabolism, Lipid

Related Publications

A Giacca, and R Gupta, and S Efendic, and K Hall, and A Skottner, and L Lickley, and M Vranic
May 1994, European journal of clinical investigation,
A Giacca, and R Gupta, and S Efendic, and K Hall, and A Skottner, and L Lickley, and M Vranic
October 1997, Journal of applied physiology (Bethesda, Md. : 1985),
A Giacca, and R Gupta, and S Efendic, and K Hall, and A Skottner, and L Lickley, and M Vranic
January 2001, The Journal of endocrinology,
A Giacca, and R Gupta, and S Efendic, and K Hall, and A Skottner, and L Lickley, and M Vranic
January 1966, Nihon geka hokan. Archiv fur japanische Chirurgie,
A Giacca, and R Gupta, and S Efendic, and K Hall, and A Skottner, and L Lickley, and M Vranic
May 1992, The American journal of physiology,
A Giacca, and R Gupta, and S Efendic, and K Hall, and A Skottner, and L Lickley, and M Vranic
January 1973, Surgical forum,
A Giacca, and R Gupta, and S Efendic, and K Hall, and A Skottner, and L Lickley, and M Vranic
January 1976, Journal of surgical oncology,
A Giacca, and R Gupta, and S Efendic, and K Hall, and A Skottner, and L Lickley, and M Vranic
January 1940, The Journal of physiology,
A Giacca, and R Gupta, and S Efendic, and K Hall, and A Skottner, and L Lickley, and M Vranic
June 2011, Molecular and cellular endocrinology,
A Giacca, and R Gupta, and S Efendic, and K Hall, and A Skottner, and L Lickley, and M Vranic
September 1999, Endocrinology,
Copied contents to your clipboard!